Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Rydex Srs Trust Biotechnology Fd: (MF: RYOIX)

(MF) As of Dec 18, 2014 06:06 PM ET

 Add to portfolio

$84.83 USD

+2.68 (3.26%)

Zacks MF Rank : 3 - Hold [?]     3    

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Nov 30, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Nov 30, 2014) 33.49
Objective Sector - Health
Peer HL MG

Zacks Premium Research for RYOIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Hold 3
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 44.49
Net Assets (Mil $) 11/30/2014 313.32
%Turnover 11/30/2014 119.00

Allocation

% of Portfolio
Large Growth 28.94
Large Value 0.00
Small Growth 32.41
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 11/30/2014 % of Portfolio
Health 58.00
Services 22.09
Other 8.05
Industrial Cyclical 5.94
Technology 5.92

Portfolio Holdings

Top Equity Holdings
(As of 9/30/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 7.75 33.15
AMGEN INC 6.17 26.39
BIOGEN IDEC INC 5.33 22.79
CELGENE CORP 5.31 22.70
REGENERON PHARMACEUTICALS 3.59 15.36
ALEXION PHARMACEUTICALS I 3.52 15.05
VERTEX PHARMACEUTICALS IN 3.38 14.44
ILLUMINA INC 2.70 11.56
BIOMARIN PHARMACEUTICAL 2.02 8.64

Stock Holding % of Net Assets

As Of 9/30/2014
Total Issues 82
Avg. P/E 40.91
Avg. P/Book 5.87
Avg. EPS Growth 16.12
Avg. Market Value (Mil $) 35,562

Risk

3 Year 5 Year 10 Year
Beta 1.09 0.98 0.87
Alpha 17.79 13.16 9.46
R Squared 0.23 0.39 0.39
Std. Dev. 20.66 20.51 20.76
Sharpe 2.18 1.55 1.00